DeepMed Research

University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma

Phase 2

Recruiting

Conditions: Mantle Cell Lymphoma

Interventions: Drug: Acalabrutinib
Drug: R-CHOP chemotherapy

First Posted Date: 2020-09-28

Last Posted Date: 2025-02-18

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 105

Registration Number: NCT04566887

Locations: 🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada
🇨🇦
QEII Health Sciences Centre, Halifax, Nova Scotia, Canada
🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

and more 2 locations

An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)

Phase 2

Recruiting

Conditions: Hepatocellular Carcinoma
Non-small Cell Lung Cancer Metastatic
Liver Metastases

Interventions: Drug: Atezolizumab
Drug: Bevacizumab

First Posted Date: 2020-09-24

Last Posted Date: 2024-07-17

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 36

Registration Number: NCT04563338

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

FAZA PETMRI Gastro-Oesophageal Study

Not Applicable

Recruiting

Conditions: Metastasized Gastro-Oesophageal Cancer

Interventions: Diagnostic Test: FAZA PET/MRI scan

First Posted Date: 2020-09-23

Last Posted Date: 2025-03-30

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 40

Registration Number: NCT04560036

Locations: 🇨🇦
Univeristy Health Network, Toronto, Ontario, Canada

Development of Upper Aerodigestive Tract Splint

Not Applicable

Terminated

Conditions: Splints

Interventions: Device: Use of Splint for UADT Visualization

First Posted Date: 2020-09-10

Last Posted Date: 2024-03-20

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 7

Registration Number: NCT04544800

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Post-Concussion Aerobic Exercise

Not Applicable

Withdrawn

Conditions: Concussion, Mild
Mild Traumatic Brain Injury

Interventions: Behavioral: Treadmill Test
Behavioral: Exercise Prescription
Device: Monitoring

First Posted Date: 2020-09-07

Last Posted Date: 2023-12-13

Lead Sponsor: University Health Network, Toronto

Registration Number: NCT04539509

Locations: 🇨🇦
Toronto Rehabilitation Institute - University Health Network, Toronto, Ontario, Canada

Deoxyhemoglobin Concentration Changes and Cerebral Perfusion Imaging

Not Applicable

Conditions: Neurovascular Disorder
Stenosis, Carotid
Stroke

Interventions: Diagnostic Test: dHb contrast and gadolinium contrast imaging

First Posted Date: 2020-09-03

Last Posted Date: 2021-04-27

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 25

Registration Number: NCT04537611

Locations: 🇨🇦
Joseph Fisher, Toronto, Ontario, Canada

Swallowing Impairment After COVID-19 Infection

Completed

Conditions: Covid19

Interventions: Diagnostic Test: Videofluoroscopic Swallowing Study (VFSS)

First Posted Date: 2020-09-03

Last Posted Date: 2023-12-06

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 44

Registration Number: NCT04537650

Locations: 🇨🇦
McMaster University, Hamilton, Ontario, Canada
🇺🇸
University of Florida, Gainesville, Florida, United States

Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial

Phase 2

Recruiting

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: Empagliflozin 25 MG + Liraglutide 1.8 MG
Drug: Liraglutide 1.8 MG + Empagliflozin 25 MG

First Posted Date: 2020-09-02

Last Posted Date: 2023-05-17

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 36

Registration Number: NCT04535960

Locations: 🇨🇦
Renal Physiology Laboratory, Toronto, Ontario, Canada

Factor In the Initial Resuscitation of Severe Trauma 2 Patients

Phase 4

Recruiting

Conditions: Traumatic Hemorrhage
Coagulopathy
Massive Hemorrhage

Interventions: Biological: Frozen Plasma
Biological: Fibrinogen + PCC

First Posted Date: 2020-09-01

Last Posted Date: 2022-12-05

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 350

Registration Number: NCT04534751

Locations: 🇨🇦
Vancouver General Hospital, Vancouver, British Columbia, Canada
🇨🇦
Hamilton Health Sciences and McMaster University, Hamitlon, Ontario, Canada
🇨🇦
Kingston Health Sciences Centre, Kingston, Ontario, Canada

and more 3 locations

Ex-Vivo COF Study for Lung Cancer Observation

Conditions: Lung Cancer

First Posted Date: 2020-09-01

Last Posted Date: 2025-03-28

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 50

Registration Number: NCT04534413

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy